BAG5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.994600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.936600E-01
Normal-vs-Stage2
9.501400E-01
Normal-vs-Stage3
2.743800E-01
Normal-vs-Stage4
2.213000E-01
Stage1-vs-Stage2
9.462600E-01
Stage1-vs-Stage3
1.201240E-01
Stage1-vs-Stage4
1.632610E-01
Stage2-vs-Stage3
1.097170E-01
Stage2-vs-Stage4
5.241500E-03
Stage3-vs-Stage4
4.554000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.987600E-01
Normal-vs-AfricanAmerican
7.097400E-01
Normal-vs-Asian
9.722400E-01
Caucasian-vs-AfricanAmerican
5.192600E-01
Caucasian-vs-Asian
9.460600E-01
AfricanAmerican-vs-Asian
7.290600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.979600E-01
Normal-vs-Female
8.961000E-01
Male-vs-Female
3.261400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.963600E-01
Normal-vs-Age(41-60Yrs)
6.546200E-01
Normal-vs-Age(61-80Yrs)
8.296600E-01
Normal-vs-Age(81-100Yrs)
5.552200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.189000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.412200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.395800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.523870E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.490300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.171800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.591400E-01
Normal-vs-Daily Drinker
5.340200E-01
Normal-vs-Weekly Drinker
7.060800E-01
Normal-vs-Occasional Drinker
4.502400E-01
Normal-vs-Social Drinker
7.838000E-01
Non Drinker-vs-Daily Drinker
5.494400E-01
Non Drinker-vs-Weekly Drinker
7.715600E-01
Non Drinker-vs-Occasional Drinker
1.123180E-01
Non Drinker-vs-Social Drinker
4.151000E-01
Daily Drinker-vs-Weekly Drinker
8.168200E-01
Daily Drinker-vs-Occasional Drinker
9.516400E-03
Daily Drinker-vs-Social Drinker
1.127780E-01
Weekly Drinker-vs-Occasional Drinker
5.939500E-02
Weekly Drinker-vs-Social Drinker
2.794400E-01
Occasional Drinker-vs-Social Drinker
4.777000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.530300E-02
Normal-vs-Grade 2
1.508340E-02
Normal-vs-Grade 3
8.983100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.977200E-01
Grade 1-vs-Grade 3
6.188600E-01
Grade 1-vs-Grade 4
9.530300E-02
Grade 2-vs-Grade 3
9.105000E-01
Grade 2-vs-Grade 4
1.508340E-02
Grade 3-vs-Grade 4
8.983100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.301600E-01
Normal-vs-NonDiabetic
9.888000E-01
Diabetic-vs-NonDiabetic
2.902600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.326000E-01
Normal-vs-NoPancreatitis
9.825200E-01
Pancreatitis-vs-NoPancreatitis
1.168210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.845400E-01
Normal-vs-N1
9.938200E-01
N0-vs-N1
9.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.779600E-01
Normal-vs-TP53-NonMutant
9.392600E-01
TP53-Mutant-vs-TP53-NonMutant
3.240100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
